IL6 and cardiovascular disorder: These substances, including interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α), contribute to a state of chronic low-grade inflammation, a hallmark of metabolic syndrome and cardiovascular disease [24,25].